These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 2074244

  • 1. An open multicentre study of the efficacy and tolerance of cefodizime 1 g bd intravenously or intramuscularly in lower respiratory tract infections.
    Sollet JP.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():103-10. PubMed ID: 2074244
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerance of cefodizime in the treatment of acute pyelonephritis.
    Kourilsky O.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():111-6. PubMed ID: 2074245
    [Abstract] [Full Text] [Related]

  • 3. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF, Palombini BC, Dagrosa EE, Mendoza F, Facco EB.
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized, dose comparison study of cefodizime in the treatment of lower urinary tract infections in women.
    Asbach HW.
    Infection; 1991 May; 19(2):85-7. PubMed ID: 2050425
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacokinetic and clinical studies on cefodizime in the pediatric field. Pediatric Study Group of Cefodizime].
    Fujii R, Arimasu O, Meguro H, Hiruma F, Sugie N, Abe T, Nakazawa S, Sato H, Narita A, Matsumoto K.
    Jpn J Antibiot; 1989 May; 42(5):1173-93. PubMed ID: 2664256
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of ceftizoxime administered twice daily in hospitalized patients with respiratory tract infections.
    Lentnek A, Wikler M, McDevitt J, Sohn C.
    Clin Ther; 1984 May; 7(1):33-9. PubMed ID: 6097357
    [Abstract] [Full Text] [Related]

  • 12. [A comparative study between cefodizime (CDZM) and cefotaxime (CTX) in respiratory tract infections].
    Takebe K, Imamura K, Masuda M, Murakami S, Tomiyama M, Tamura T, Endou K, Ishimaru K, Okushima T, Nakazono M.
    Kansenshogaku Zasshi; 1989 Apr; 63(4):318-51. PubMed ID: 2506292
    [Abstract] [Full Text] [Related]

  • 13. Cefepime versus cefotaxime in the treatment of lower respiratory tract infections.
    Barckow D, Schwigon CD.
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():187-93. PubMed ID: 8150762
    [Abstract] [Full Text] [Related]

  • 14. Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea.
    van der Willigen AH, Wagenvoort JH, Schalla WO, Knapp JS, Boot JM, Heeres-Weststrate PL, Michel MF, van Klingeren B, Stolz E.
    Antimicrob Agents Chemother; 1988 Apr; 32(4):426-9. PubMed ID: 3377456
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical experience with cefodizime in pediatric field].
    Sekiguchi T, Okamoto T, Ohara K, Kouzan H, Nishimori M, Miyazaki M.
    Jpn J Antibiot; 1989 Jun; 42(6):1391-8. PubMed ID: 2795863
    [Abstract] [Full Text] [Related]

  • 17. Cefodizime in clinical use: a review of the clinical trial reports.
    Grassi GG.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():117-25. PubMed ID: 2074246
    [Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of cefotiam and cefamandole in respiratory tract infections.
    Beumer HM, Olislagers WP, Kahn M, van Hamersveld JD.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):105-8. PubMed ID: 3886564
    [Abstract] [Full Text] [Related]

  • 19. [Clinical studies of cefodizime in the pediatric field].
    Niino M, Kida K, Matsuda H, Murase M.
    Jpn J Antibiot; 1989 Jun; 42(6):1400-13. PubMed ID: 2795864
    [Abstract] [Full Text] [Related]

  • 20. Cefodizime (HR221) versus norfloxacin for treatment of urinary tract infections.
    Esposito S, Sardaro C, Gaeta GB, Galante D, Giusti G, Basani F.
    J Chemother; 1991 Feb; 3(1):42-4. PubMed ID: 2019862
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.